Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€122.80

€122.80

0.160%
0.2
0.160%
-

-

 
22.06.21 / Tradegate WKN: 929138 / Symbol: A / Name: Agilent / Stock / Healthcare Equipment & Supplies / Large Cap /
Latest predictions
€104.00
09.03.21
21.75%
buy
-
08.09.20
52.55%
-
31.05.20
53.14%
buy
€99.00
18.06.19
92.41%
buy
€67.65
16.01.19
94.68%
buy
€64.94
09.09.18
103.60%
buy
Best running prediction
€64.94
09.09.18
103.60%
buy
Your prediction

Agilent Technologies Inc. Stock

Agilent Technologies Inc. gained 0.160% compared to yesterday.
Our community is currently high on Agilent Technologies Inc. with 5 Buy predictions and 1 Sell predictions.
So far the community has only identified positive things for Agilent Technologies Inc. stock. The most positive votes were given for criterium "EBIT Margin".

Pros and Cons of Agilent Technologies Inc. in the next few years

Pros
1
Higher EBIT margin than peer group
1
Market Leader or Top 3
1
Known brand
Cons
0
-

Performance of Agilent Technologies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Agilent Technologies Inc. 0.160% 2.977% 13.076% 56.095% 28.735% 126.652% 199.512%
Hologic Inc. -0.300% 4.117% 4.645% 8.984% -6.748% 56.099% 75.919%
Waters Corp. -0.690% 2.837% 13.281% 69.591% 43.564% 70.368% 144.149%
Cerner Corp. -1.390% 0.060% 4.054% 4.679% 3.388% 27.126% 35.115%

Comments

Buy Agilent Technologies Inc.
Show more

Sell Agilent Technologies Inc.
Show more

Prediction Buy
Perf. (%) 21.61%
Target price 125.000
Change
Ends at 17.10.20

Buy with target price 125.0
Show more

Other discussions about Agilent Technologies Inc. Stock

Trading Agilent Technologies Inc.

Trading Agilent Technologies Inc.

New thread Forum

News

Agilent Completes the InfinityLab Bio LC Portfolio :
Agilent Completes the InfinityLab Bio LC Portfolio


Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the

Agilent Presents Thought Leader Award to Dr. Stéphane Bayen: https://mms.businesswire.com/media/20210614005189/en/884806/5/stephane_bayen.jpg
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen


Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancerhttps://www.cyansecurity.com/:
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer


Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO)